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EXECUTIVE SUMMARY
Little is known about what states with large rural populations are doing to combat opioid use
disorders (OUDs) in rural areas. Rural residents with OUDs tend to have multiple socioeconomic vulnerabilities that may negatively impact their ability to access treatment and
recovery services. Additionally, the rural health care system is characterized by numerous
resource, workforce, access, and geographic challenges that complicate the delivery of
specialized care for OUDs in rural communities. The nature and scope of the opioid crisis vary
across rural communities and require multifaceted, community-based strategies to address the
problem. Based on interviews with key stakeholders in Indiana, North Carolina, Vermont, and
Washington State, this qualitative study explores promising state and community strategies to
tackle the opioid crisis in rural communities and identifies rural challenges to the provision of
OUD prevention, treatment, and recovery services.
FINDINGS
Rural Challenges to the Prevention and Treatment of Opioid Use Disorders
Key stakeholders identified the following challenges to the prevention and treatment of OUDs in
rural communities:
•

Significant variation in opioid prescribing patterns due to inconsistent use of evidencebased prescribing guidelines and limited access to specialty pain management support;

•

Continued stigmatization of individuals with OUDs;

•

Emphasis on criminalizing OUDs rather than treating them as chronic diseases;

•

Limited access to specialty substance use and mental health services;

•

Difficulties recruiting and retaining an adequate substance use treatment workforce;

•

Impediments to inter-agency collaboration in poorly-resourced rural areas; and

•

Barriers to the implementation of harm reduction strategies involving needle exchanges.

Promising Strategies for Addressing Opioid Use in Rural Areas
The results of our interviews identified the following promising strategies to OUD prevention
and treatment that are relevant to rural areas:
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•

Engaging the local community to address opioid issues, including broad-based coalitions;

•

Encouraging prescribers to adopt evidence-based opioid prescribing guidelines;

•

Implementing hospital emergency department (ED) protocols to manage access to
opioids;

•

Expanding access to medication-assisted treatment (MAT) through primary care-based
models;

•

Supporting community buprenorphine prescribers through hub and spoke and telehealth
models; and

•

Developing models to support recovery and reduce relapse in rural communities.

IMPLICATIONS FOR POLICY AND PRACTICE
The complexity of opioid use in rural communities calls for community-based organizing and
engagement strategies that tap into the expertise of local, rural stakeholders to reduce OUDs and
related harms. Although the expanded use of buprenorphine in primary care settings is a
frequently discussed rural strategy, traditional substance use treatment, mental health, and care
coordination services are equally important components of an OUD system of care. Prevention
strategies to reduce OUDs, harm reduction initiatives to reduce overdose deaths and exposure to
bloodborne infectious diseases, and recovery resources to support individuals in maintaining
gains made during treatment are also essential to reducing the consequences of OUDs.
Additional research and funding are needed to target prevention, harm reduction treatment, and
recovery strategies to the unique challenges of rural communities. Federal and state governments
and foundations can make important contributions to addressing the opioid crisis in rural
communities by funding evidence-based strategies and programs, providing or expanding access
to evidence-based interventions, supporting research into best practices and dissemination
activities, and strengthening the use of telehealth technology to improve access to direct care and
consultative services to support rural clinicians.
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INTRODUCTION
The current opioid epidemic is a complex problem reflecting the many challenges inherent in our
healthcare system. Opioids * are a class of prescription medications providing significant benefits
to patients with acute, severe pain due to intractable, chronic pain that is not adequately managed
with more conservative methods, traumatic injuries, and bone and other cancers.1,2 Opioid
addiction is associated with several factors, including expanded use of opioids beyond the
narrower scope of conditions for which they are most appropriately suited, early failure to
acknowledge the risks of prescription opioids, slow adoption of evidence-based opioid
prescribing guidelines by health care professionals, and growing patient demand for opioids.3-9
Moreover, expanded prescription opioid use is directly linked to increased heroin use, as the cost
of heroin has declined and the supply has increased relative to prescription opioids.4
Recent research conducted by the Maine Rural Health Research Center suggests that the
prevalence of non-medical, prescription opioid and heroin use in the past year was slightly
higher among urban than rural residents. Rural users, however, tend to have multiple socioeconomic vulnerabilities that negatively impact their ability to access and successfully complete
treatment; rural past-year use rates were significantly higher than urban past-year use rates
among those who were under age 20, unmarried, with low educational attainment, no insurance
coverage, and low-income, corroborating findings from other studies.10 At the same time, rural
travel barriers (e.g., costs, lack of public transportation, long travel distances, weather)
exacerbate access challenges.10
In its January 2013 report to Congress on the nation’s substance abuse and mental health
workforce issues, SAMHSA officials identified a number of long standing substance use
workforce problems including high turnover rates, recruitment and retention challenges, worker
shortages, an aging workforce, stigma, and inadequate compensation levels. As of March 2012,
HRSA reported almost 3,700 Mental Health, Health Professional Shortage Areas covering

*

The term "opioid" previously referred only to synthetic opiates and is now commonly used to refer to all natural,
synthetic, and semi-synthetic opiates (see National Alliance of Advocates for Buprenorphine Treatment,
https://www.naabt.org/education/opiates_opioids.cfm). Consistent with current usage, we use the term “opioid” in
this paper to refer to all opioids and opiates, and we jointly refer to non-medical use of pain relievers and heroin as
opioid use.
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almost 91 million people. Rural areas are more heavily impacted by these workforce issues than
urban areas. Approximately 55 percent of United States (U.S.) counties, all of which are rural,
have no specialty mental health professionals.11 These workforce challenges are likely to be
exacerbated by the growing demand for substance use treatment including treatment for opioid
use disorders (OUDs).
A critical component of a system of care to address OUDs is the availability of medication
assisted treatment (MAT) involving prescription of methadone, buprenorphine, and naltrexone to
ease cravings and facilitate withdrawal. MAT is an evidence-based intervention that is widely
recognized as an essential element of effective treatment for OUDs. Although MAT is a critical
tool, it is insufficient on its own to address an opioid user’s full range of needs. MAT must be
supplemented by substance use, mental health, and physical health services to address the issues
underlying opioid use. Care coordination services are essential to assisting individuals with
OUDs in obtaining the full range of treatment, social supports, and recovery services necessary
to achieve and maintain an opioid free life. Finally, recovery services are a necessary component
of care to reduce the potential for relapse and maintain gains made in treatment.
The complexity of OUDs calls for a multifaceted, community-based public health approach.8,12-15
Little is known, however, about what states with large rural populations are doing to help combat
the opioid crisis in rural areas. To address this question, we conducted key informant interviews
in four states to learn about the strategies states and communities are taking to address this
growing crisis. This paper discusses the opioid epidemic, especially as it pertains to rural
communities. We provide a brief overview of the scope of the opioid problem, existing treatment
infrastructure, prescription drug monitoring and other prevention programs, and
barriers/facilitators to addressing the opioid epidemic in each state. We then summarize from our
state interviews, common rural themes and describe seven promising strategies for addressing
rural OUDs. The paper concludes with a discussion of implications for states and policy.
BACKGROUND
Scope of the Problem
OUDs are the fastest growing class of substance use disorders in the United States (U.S.)12 and
the primary cause of unintentional drug overdose deaths.16 Since 2005, past year non-medical
use of prescription pain medication was slightly higher among urban residents than rural
2
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residents.17,18 Multiple studies, however, document higher use among some rural sub-populations
(compared to their urban counterparts) including youth,19,20 pregnant women,21 women
experiencing domestic/partner violence,22 and persons with co-occurring disorders.23 Heroin use
has also grown substantially in recent years, particularly among those reporting prior use of
prescription opioids.17,24,25 Heroin initiation is 19 times higher among this group compared to
those who have not used prescription opioids non-medically. Rural opioid users tend to be
younger, in worse health, less educated, lower-income, and more likely to be uninsured than
urban users.10
Rural areas suffer from significant workforce shortages as well as gaps in the availability of
substance use treatment services in general and for medication assisted therapy services in
particular.26,27 As mentioned earlier, 55 percent of counties, all rural, have no psychiatrists,
psychologists, or social workers.11 Rural residents wait longer to access treatment and travel
further to obtain care. At the same time, the spread of human immunodeficiency virus (HIV) and
Hepatitis-C (HCV) due to injection drug use creates an additional challenge for rural areas, many
of which have limited access to infectious disease services.
Addressing OUDs is further complicated by the complex relationship between prescription
opioid and heroin use. The Director of the Centers for Disease Control and Prevention (CDC)
described this complexity noting that the growth in heroin use was attributable to the increased
numbers of Americans who are “primed for heroin addiction because they are addicted to or
exposed to prescription opioid painkillers” and the decreasing cost of heroin.4 As efforts to
reduce access to prescription opioids make it more difficult to obtain these medications either
legally or illegally, users may turn to heroin, which is cheaper and can be easier to obtain in
some communities, as a substitute.
Another contributing factor to the opioid crisis is the significant variation in opioid prescribing
rates. CDC data reveal that U.S. providers write twice as many opioid prescriptions per person as
Canadian providers with wide variations in prescribing practices across the 50 states. Providers
in the highest prescribing states write three times as many opioid prescriptions as those in the
lowest prescribing states.28,29 The three states with the highest prescribing rates (i.e., Alabama,
Tennessee, and West Virginia) also have significant rural populations. Ten southern states (North
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Carolina, South Carolina, Arkansas, Louisiana, Mississippi, Oklahoma, Kentucky, West
Virginia, Tennessee and Alabama) and three mid-western states (Michigan, Indiana, and Ohio)
are in the top quartile of states in terms of the rates of prescriptions for pain medications. These
13 states all have significant rural populations.
State Strategies
The relationship between the use of prescription opioids and heroin requires states to work on
several fronts to address this crisis.8,12-15 The White House Office of National Drug Control
Policy’s30 (ONDCP) 2015 National Drug Control Strategy reflects a broad-based, multifaceted
public health approach emphasizing prevention, early identification and treatment, recovery
support, and enhanced enforcement activity. In support the ONDCP’s30 approach, Kolodny and
colleagues8 argue for a focus on primary prevention (i.e., preventing new cases of OUDs);
secondary prevention (i.e., identifying early cases of OUDs); and tertiary prevention (i.e.,
ensuring access to effective treatment and recovery services). Tertiary prevention includes MAT,
psychosocial substance use and mental health treatment, harm reduction interventions (e.g.,
naloxone to prevent overdoses and needle exchanges to reduce HIV and HCV transmission), and
recovery services to support those attempting to make long-term behavioral changes to avoid
relapse. Reflecting the ONDCP’s public health approach, state strategies include prescription
drug monitoring programs, legislatively mandated prescribing guidelines to reduce excess
prescribing patterns and the supply of prescription opioids, and expansion of harm reduction,
prevention, treatment, and recovery services.
The Federal Government has undertaken a number of activities that can inform the development
of state policies regarding opioid use and prescribing patterns. These include funding research by
the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services
Administration (SAMHSA), and other agencies to address different aspects of opioid use, pain,
next generation analgesics, and treatment of opioid use.31 In March 2016, the Centers for Disease
Control and Prevention released its prescribing guidelines for primary care clinicians prescribing
opioids for chronic pain.5 These guidelines provide an agreed upon evidence-based framework to
inform decisions on when to initiate or continue opioids for chronic pain; specific prescribing
issues (i.e., opioid selection, dosage, duration, follow-up, and discontinuation); and assessing risk
and addressing harms of opioid use.
4
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States have also been responded to the opioid crisis by implementing opioid prescribing
guidelines. The State of Washington, as will be discussed in the paper, has taken multiple routes
to the development of opioid prescribing guidelines including interagency initiatives driven by
the medical directors of state health agencies as well as legislative action. California, Maine,
Massachusetts, New York, Ohio, and Pennsylvania have passed legislation implementing or
strengthening opioid prescribing guidelines.32 As an alternative to legislative action, medical
and/or hospital associations in Connecticut, Indiana, North Carolina, and New Hampshire have
taken the lead on the development of recommended opioid prescribing guidelines, including
guidelines for use by emergency departments (EDs). Oregon and West Virginia have
implemented prescribing policies based on the CDC’s opioid prescribing guidelines.
The nature and scope of the opioid crisis varies across rural communities, requiring multifaceted,
community-based strategies to combat the problem. Key components of a comprehensive
community-based strategy include:
•

The education of law enforcement officials, healthcare and social service providers, and
community members to promote the understanding of substance use disorders as a
chronic disease rather than a law enforcement problem and to reduce related stigma;

•

The promotion of evidence-based prescribing guidelines, screening tools, and treatment
protocols by hospitals, primary care providers, and other clinicians; and

•

The expansion of access to treatment, harm reduction, prevention, recovery, and other
support services.8,12-14,30,33-35

We used this framework to identify relevant state and local agencies engaged in the abovementioned practices, recruit key informants to participate in our study, and guide our selection of
promising state and local strategies used to address the opioid crisis in rural communities.
METHODS
As noted, this study examined strategies in four states to address the opioid crisis in rural areas.
The study objectives were to identify and assess the opportunities and challenges associated with
rural implementation of the states’ strategies to: (1) develop comprehensive community-based
education programs targeting the risks and realities of opioid use and the role of law
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enforcement, healthcare, and communities in addressing the ongoing crisis, (2) engage local
healthcare systems and providers in the implementation of evidence-based prescribing practices
and appropriate tools to screen for and treat OUDs and co-occurring mental health problems, and
(3) implement integrated opioid strategies involving treatment, harm reduction, prevention, and
recovery to reduce prescription drug diversion. To inform our selection of states and key
informants, we convened a multi-disciplinary advisory panel of substance use experts from
federal agencies, state government, and policy centers. The Panel also provided input on our key
informant interview protocols. Members of the Advisory Panel included Andrea Boxill, Deputy
Director of the Governor’s Opiate Action Team, Ohio Mental Health and Addiction Services;
Barbara Cimaglio, Deputy Commissioner, Alcohol & Drug Abuse Programs, Vermont
Department of Health; Peter Kreiner, Principal Investigator, PDMP Center of Excellence,
Brandeis University; and Kathryn Power, Regional Administrator, Region One, SAMHSA.
With the panel’s input, the study team selected four states - Indiana, North Carolina, Vermont,
and Washington - based on two main criteria: (1) evidence of significant rural opioid problems,
and (2) a history of recent and ongoing significant initiatives that included rural community
interventions. Using semi-structured interview protocols, we spoke with four to six key
informants in each state (N=22) between September 2015 and January 2016. Key informants
included state government and public health officials, clinicians, OUD professionals,
prescription drug monitoring program representatives, and law enforcement officials. Interviews
covered five main topics: (1) the nature and scope of the state’s rural opioid problem; (2) the
state’s OUD infrastructure and rural gaps; (3) the state’s prescription drug monitoring program
(PDMP); (4) challenges in addressing rural opioid use; (5) specific state or community strategies;
and (6) the perceived impact of the state’s or community’s efforts to address its opioid use
problems.
Interview data were analyzed within and across states for key themes, and were organized and
summarized according to the six areas of inquiry listed above. We also drew on information from
publicly available documents, including reports, data summaries, evaluation studies, and plans
produced by state and community agencies and substance treatment and prevention programs.

6
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THE RURAL OPIOID PROBLEM AND STATE STRATEGIES: AN OVERVIEW
Indiana
Scope of the Rural Opioid Problem
The opioid problem in rural Indiana rose to national prominence due to substantial outbreaks of
HIV and HCV linked to intravenous (IV) prescription medication misuse in rural Scott County
located in the southeastern region of the state near the Kentucky border. During a six-month
window in 2015, Scott County experienced 184 new cases of HIV36 and 280 new cases of HCV
(interview with Kevin Moore, Indiana Division of Mental Health and Addiction, November 2,
2015). These outbreaks were linked to misuse of the prescription opioid oxymorphone (known
by the brand name Opana).37 Although prescription opioid use is more common in Scott County,
state officials noted that rural “hot spots” of heroin use and overdoses had surfaced across the
state, driven by the low cost of heroin (roughly $8 per day) and restrictions in the availability of
prescription opioids. Officials also reported significant prescription drug problems in several
other parts of the state including northeastern Indiana where methamphetamine use is also a
serious concern.
Prior to the Scott County crisis, Indiana’s General Assembly passed a moratorium on new
methadone treatment programs beyond the existing 13 programs located primarily in urban areas
of the state at the time of our study. These 13 programs serve approximately 15,000 people per
year. Ten of these programs are proprietary and three are located in community mental health
centers (CMHCs). Indiana’s Medicaid program does not reimburse for methadone treatment for
substance use (only for pain management). As a result, most services are provided on a cash-only
basis. Their location in urban areas and cash-only operating policies create access barriers for
low-income rural residents.
Rural OUD Strategies
The outbreak of HIV and HCV in Scott County was exacerbated by existing Indiana statute
classifying the use of needles for nonmedical purposes as a felony punishable by up to three
years in prison.38 In late March 2015, the governor declared a public health emergency in Scott
County which allowed him to suspend the law thereby paving the way for the development of a
needle exchange.
Maine Rural Health Research Center
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Following the Scott County crisis, the General Assembly passed legislation allowing the
Division of Mental Health and Addiction to approve up to five new hospital or CMHC-based
opioid treatment programs (OTPs). As of December 2016, approximately 312 physicians in the
state had SAMHSA waivers to prescribe buprenorphine but not all were operating at full
capacity.39† As with OTPs, these providers are clustered in more heavily populated areas and are
difficult for rural residents to access. In addition, 190 traditional substance use treatment
programs are certified by the state to provide treatment services and most are located in
urbanized areas. In July 2015, the state received SAMSHA funding to develop a MAT health
home model in rural settings. Although state officials are cautiously optimistic about its success,
transportation issues, the limited availability of resources to develop a comprehensive,
community-based buprenorphine treatment system using a hub (specialty substance use and OTP
services) and spoke (primary care and community-based buprenorphine services, supported by
the hub specialty services) model, and limitations on patients’ ability to pay for services are
ongoing barriers to the development of services in rural areas.
Indiana’s prescription drug monitoring program (PDMP), known as INSPECT, was established
by the state’s General Assembly in 2004. As of January 1, 2016, licensed pharmacies must report
schedule II - V controlled substances prescription data to INSPECT every 24 hours. INSPECT
data can be accessed by many entities, including healthcare providers. As prescriber participation
is not mandatory, program officials stressed the importance of ongoing, collaborative educational
efforts with the Indiana State Medical Association to “bring providers along”. The fear is that
mandatory prescribing and reporting rules would discourage providers from prescribing pain
medications, particularly in rural communities. Other prevention/opioid reduction strategies in
Indiana include a prescription drug disposal program and a broad public service campaigns with
multiple, high profile sponsors (e.g. the Indianapolis Colts professional football team).

†

Under the terms of the Drug Addiction Treatment Act of 2000, qualified physicians may apply for waivers to treat
opioid dependency with buprenorphine in settings in which they are qualified to practice, including office,
community hospital, health department, or correctional facility settings (https://www.samhsa.gov/medicationassisted-treatment/buprenorphine-waiver-management/qualify-for-physician-waiver). Under the waiver process,
SAMHSA verifies the qualification of the applicant and the Drug Enforcement Agency assigns the physician a
special identification number. Upon receipt of the waiver, a physician may prescribe buprenorphine to a maximum
of 30 OUD patients at a time for the first year. After the first year, the physician may apply to SAMHSA for
approval to treat up to 100 patients at a time. Under new federal regulations, physicians who have prescribed
buprenorphine to 100 patients for at least one year can apply to SAMHSA to increase their patient limits to 275.
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North Carolina
Scope of the Rural Opioid Problem
Key informants emphasized prescription medication use as a key driver of the opioid problem in
North Carolina, however, they also noted that heroin addiction had also risen in recent few years.
A 2016 study found that three North Carolina communities (Wilmington, Fayetteville, and
Hickory) were among the top 25 American cities for opioid misuse (based on the percentage of
opioid prescriptions misused).40 The state’s Opioid Treatment Authority reported an increase in
heroin overdose deaths, with prescription drug overdose deaths dropping slightly as heroin
overdose deaths rose. Stakeholders described opioid users in some rural communities as younger,
blue collar, middle class users, primarily addicted to oxymorphone (Opana). Stakeholders
reported a recent uptick in younger users presenting at treatment clinics with acute exposure to
prescription opioids, rather than with long-term addiction. Treating these users has been difficult
since commercial insurance plans often require one year of addiction before covering MAT.
According to key informants, EDs have experienced the effects of the opioid crisis with 12-15
percent of ED patients reportedly being admitted for substance use and withdrawal concerns.
Rural OUD Strategies
Key informants noted that rural North Carolina lacks treatment resources. Rural residents must
drive significant distances to access services and the majority pay for treatment out of pocket. As
of December 2016, 463 physicians had SAMHSA waivers to prescribe buprenorphine, however,
limited data are available to describe their overall service volume in relation to their capacity.39
Outside of federal block grant funds, North Carolina lacks a robust payment system for
substance use treatment. Most of the state’s 54 OTPs are private, for-profit entities, typically
located in urbanized areas.41 Few accept Medicaid and approximately two-thirds are cash-only
facilities. Patients with private insurance also have trouble accessing treatment as many plans
will not cover methadone and buprenorphine services and patients are forced to pay out-ofpocket for treatment.
Substance use and mental health services for Medicaid and indigent individuals are provided by
seven regional Local Management Entities (LMEs)/Managed Care Organizations (MCOs)
responsible for managing, coordinating, and monitoring the delivery of mental health, substance
Maine Rural Health Research Center
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use, and developmental disabilities services in their service areas. One rural OTP provider noted
that the process to contract with LMEs/MCOs to treat indigent patients can be difficult.
North Carolina’s PDMP came online in 2007. Officials reported that only 27 percent of
practicing physicians use the PDMP but they are seeing steady growth. Recently, a notification
system was added that raises an alert when a physician has a concerning prescribing pattern. The
PDMP advisory group has been careful not to alienate physicians and promotes the PDMP as a
positive way to serve patients and minimize OUDs. North Carolina allows a limited, discrete
group of law enforcement officials to access PDMP data to minimize the impression that
physicians are being “surveilled” by law enforcement in order to encourage wider use.
North Carolina has an important community-based prevention and harm reduction program,
Project Lazarus, which started in rural Wilkes County, but has since been expanded statewide.
As discussed later in this paper, Project Lazarus is deeply embedded in rural communities across
North Carolina as well as in other states and is a proven model for helping communities tailor
environmental strategies for addressing and preventing substance misuse.42 The Wilkes County
site also provides technical assistance to communities to build prevention capacity while also
meeting the needs of patients being treated for chronic pain.
In 2013, North Carolina received a SAMHSA Partnerships for Success grant to reduce and
prevent opioid prescription drug misuse among 12-25 year olds in high need communities, the
majority of which are rural. In addition, North Carolina’s LMEs/MCOs subcontract for
prevention services with a network of non-profit organizations and community coalitions.
Vermont
Scope of the Rural Opioid Problem
In Vermont, key informants noted that prescription opioid misuse increased sharply in the 1990s,
but has stabilized and declined since 2010. According to a 2015 Data Brief released by the
Vermont Department of Health,43 prescription OUDs have declined since 2010 with the greatest
decrease among 18 to 25 year olds. Heroin use has been increasing since 2010, as evidenced by
increased ED fatalities involving heroin. Stakeholders reported little variation in rates across the
state or across urban and rural areas.

10
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Rural OUD Strategies
In 2013, the number of people entering treatment for OUDs in Vermont exceeded the number
entering treatment for alcohol.44 Opioid use is the number one reason Vermont residents enter
substance use treatment. The opioid crisis has been a focus of policy in Vermont since 2014,
when Governor Peter Schumlin focused his State of the State Address on Vermont’s opioid
crisis. He noted that Vermont had the second highest rate of admission to state-funded substance
use treatment programs in the U.S., the result, he believes, of the state’s efforts to view substance
use disorders as a chronic disease rather than a problem of criminal behavior.45 The number of
people receiving treatment for either heroin or prescription opioids in 2014 increased
substantially over a five year period.43 Despite improvements in access, heroin-related ED visits
increased through 2014 while ED visits related to prescription opioids remained stable.43
The Vermont Department of Mental Health oversees a publicly-funded treatment system; most
are Medicaid-funded providers. As discussed later, Vermont has aggressively developed a “hub
and spoke” model of OUD treatment in which specialty OTPs (hubs) support community
providers offering MAT services (spokes). The model serves both urban and rural communities,
and has encouraged local primary care providers to take on more MAT patients and apply for the
expanded waiver to increase their capacity. In a 2015 report to Vermont Legislature,
representatives from the Vermont Department of Health noted that the hub and spoke system of
care is “designed to provide a continuum of timely, interconnected and coordinated components
with multiple entry points.”46
Participants include Department of Health, Alcohol and Drug Abuse Programs-preferred
providers, community-based organizations and non-profit agencies, schools, recovery centers,
transitional housing agencies, the courts, other state agencies, and physical and behavioral health
providers. Rural spoke providers include primary care practices and physicians in Critical Access
Hospitals. As of December 2016, 58 Vermont physicians had waivers to prescribe buprenorphine
in primary care, psychiatric, and substance use treatment settings.39 Vermont is served by 10
OTPs, most of which are located in larger communities.41
In addition to treatment services, Vermont’s system includes specialized substance use
prevention consultants in the state’s 12 district offices who work with communities on
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community-based prevention. Vermont also has 12 recovery centers providing information and
support and peer recovery coaches supported by state funds serving both urban and rural
communities.
Launched in 2008, Vermont’s PDMP requires schedule II, III, and IV prescribers to register with
the system and pharmacies to enter prescription data into the system. Use of the registry is
voluntary except under certain required circumstances (i.e., the first time a provider prescribes an
opioid to treat chronic pain, annually for patients receiving ongoing opioid treatment, or when
opioids are prescribed to treat acute pain with a duration of more than 21 days). The PDMP
notifies providers when they have patients receiving multiple prescriptions through multiple
pharmacies and suggests that they coordinate care. Vermont works to encourage more providers
to use the system and engage prescribers in training opportunities. Law enforcement officials do
not have access to PDMP data which is a source of frustration among the law enforcement
community.
The Vermont Health Department has developed a statewide safe storage and prescription drug
storage campaign called ‘Vermont’s Most Dangerous Leftovers’ campaign. This initiative was
launched in 2015 and supports regional prescription drug misuse prevention strategies.
Washington State
Scope of the Rural Opioid Problem
According to key informants, prescription opioid drug overdoses declined substantially between
2008 and 2014 (from 512 to 319) while heroin overdoses doubled to 293 deaths during the same
time period.47 Informants noted that total opioid overdose deaths outnumber deaths from all other
drugs. They also noted that three-quarters of heroin users in Washington start with prescription
opioids.47 Heroin overdose victims tend to be younger (25 to 34 years old) compared to those
who overdose on prescription opioids (45 to 54 years old), and overdose rates are higher in rural
communities.47 Key informants attributed this trend, in part, to rural occupational injuries and
limited access to necessary specialty and pain management services in many rural areas.
Rural OUD Strategies
In January 2016, the Unintentional Poisoning Workgroup, with representatives from state
agencies, professional associations, academic institutions, and local entities, released its updated
12
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statewide working plan for responding to the opioid crisis. The plan addresses four priority
goals: prevention of opioid misuse; treatment of opioid use and dependence; prevention of
overdose deaths; and use of data to detect opioid use, monitor morbidity and mortality, and to
evaluate interventions.48
According to respondents, access to substance use treatment services in rural communities
remains an ongoing problem. Substance use services for Medicaid enrollees are accessed through
one of nine behavioral health organizations under state contract to manage and coordinate access
to and the delivery of behavioral health care. Covered services include: assessment, brief
intervention and referral to treatment, detoxification, outpatient, residential treatment, MAT, and
case management.49 The state is served by 23 OTPs of which 13 are non-profit, six are for profit,
two are Veterans Affairs facilities, and two are publicly/governmentally owned.39 The majority
are located in urban areas as are Washington’s 429 physicians with a SAMHSA buprenorphine
waiver.41
As discussed later in this report, the Washington legislature has passed legislation to address
opioid issues including rules and prescription guidelines for chronic, non-cancer pain, dosing
limits, and “Good Samaritan” laws to encourage use of naloxone to reverse opioid overdoses.
Washington’s PDMP collects over 11 million records annually and is accessible to health care
providers, relevant government healthcare authorities, and state, local, and federal law
enforcement agencies. Interviewees reported that approximately 30 percent of prescribers are
participating in the PDMP. Provider registration is voluntary, but ED physicians are required by
state worker’s compensation rules to register when prescribing opioids to an injured worker.
Federal program enhancement grants have allowed the state to connect the PDMP with the state
health information exchange, connect to PDMPs in neighboring states, and support an evaluation
of the program. Prescribers employed by OTPs are required to check the PDMP when treating
patients for OUDs. Efforts have been made to simplify the PDMP registration process, including
allowing providers to register with the PDMP through their “One Health Port,” a centralized
portal for prescription ordering procedures. The state is working to integrate and embed the
PDMP into electronic health records to allow healthcare providers to seamlessly access PDMP
information and reduce provider concerns that they do not have enough time to check PDMP
reports for patients.
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The state’s prevention efforts include broad-based educational programs for providers and the
public on the prescription of opioids for pain and potential risks associated with it; increased
monitoring and tracking of substance use, including opioids; evaluation of regulations and
guidelines for the treatment of chronic, non-cancer pain with opioids; and education of patients
and providers using a “Take as Directed” website.
The state has hired an epidemiologist to work with county health departments, including those
covering rural areas, to develop data on controlled substance use. This effort is being combined
with a grant through the Bureau of Justice Assistance for controlled substance prescriptions,
using data mapping tools to overlay substance use data with hospital admission, death, and
treatment data to identify trouble spots with high, at-risk behavior rates, deaths, and lack of
treatment. Also, the Department of Health, law enforcement, and environmental groups have
developed and supported medication “take back” programs to prevent opioid diversion.
Rural Barriers & Challenges to OUD Prevention and Treatment
Our key informant interviews revealed several commonly identified barriers and challenges to
addressing opioid use in rural communities, including:
•

Difficulties in maintaining an adequate prevention, treatment, and recovery workforce
limits the ability to develop effective services for opioid and substance use disorders in
rural areas. Most rural communities and regions lack the critical mass of patients needed
to recruit, support, and retain adequate staff and operate a sustainable service system.

•

Many primary care and specialty providers are not fully informed about or do not use
current evidence-based protocols for prescribing opioids. Key informants expressed
concern that negative publicity regarding prescribing practices may discourage rural
primary providers from prescribing pain medications. Others noted that provider efforts
to reduce opioid prescriptions can have a negative impact on providers’ patient
satisfaction ratings.

•

Stigma associated with the view that characterizes opioid use as a “moral failing” and/or
criminal activity rather than a chronic disease is still common in many rural communities.
While stigma is also an issue in urban communities, it has a disproportionate impact in
rural areas given the social and environmental characteristics of rural communities and
the relative lack of anonymity of the people who live in them.50,51 Stigma is an ongoing
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problem that can discourage individuals from seeking treatment. It also contributes to
local residents’ perception of treatment programs as magnets that will attract “addicts” to
the community. Finally, it can discourage legislators from developing and funding
programs and interventions necessary to address the opioid crisis.
•

Inadequate access to substance use and mental health services in rural areas is a
continuing problem that requires patients to leave their community for care, resulting in
transportation and cost barriers. These can be significant impediments to using services,
especially those that require daily encounters, such as methadone treatment programs.

•

Despite a strong evidence base, MAT services are controversial among some
policymakers who believe medication-based treatments only substitute one opioid for
another (methadone and buprenorphine are opioid agonists with potential for abuse). As a
result, states vary in the extent to which they support expansion of MAT services.

•

Financial access to OTP and substance use services is a problem, with limited private and
public insurance coverage and many OTP programs operating as cash only businesses.

•

Inter-agency collaboration to address opioid problems can be difficult in poorlyresourced rural areas. Respondents noted that substance use, mental health, and physical
health systems have not typically worked well together, making integration of care
challenging.

PROMISING STRATEGIES FOR ADDRESSING RURAL OPIOID MISUSE
Key informants described a variety of strategies for addressing the opioid crisis in rural areas.
Strategies span community-based prevention, harm reduction, treatment, and recovery.
Prevention programs include North Carolina’s Project Lazarus and Washington’s programs to
assist rural physicians with chronic pain management and introduce evidence-based opioid
prescribing protocols in rural EDs. Harm-reduction programs include needle exchanges in
Indiana and Project Lazarus’s efforts to reduce overdose deaths. Initiatives targeting improved
rural access to OUD treatment include Vermont’s “hub and spoke” treatment service model. All
four states are pursuing enhanced support programs for physicians adopting MAT. Vermont’s
Recovery Network is a statewide initiative providing peer support and recovery services to assist
individuals with substance use disorders in maintaining sobriety. The following narrative briefly
describes these promising approaches.
Maine Rural Health Research Center
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Engaging the Local Community to Address Opioid Issues: North Carolina’s
Project Lazarus
Focusing on the local community and its resources is a central tenet of a public health approach
to addressing the current opioid crisis. This theme was echoed by a number of key informants
interviewed. When discussing the HIV/HCV and opioid crisis in Scott County, officials
highlighted the importance of working with communities to address underlying infrastructure,
stigma, social, and economic issues related to opioid use. They reported working with key
community leaders to encourage the development of prevention activities, harm reduction
programs such as needle exchanges, and educational efforts to assist people who use opioids in
understanding the dangers of both medical and illicit opioid use.
Project Lazarus offers a community engagement model that has been successfully adopted in
rural communities throughout North Carolina and in other states.42 Based in rural Wilkes
County, North Carolina, Project Lazarus grew out of a local hospice director’s concerns about
his patients’ opioid use and addiction and the unwillingness of some local providers to write
prescriptions for hospice patients in need of pain relief. The county’s prescription opioid
overdose death rate was four to five times greater than state and national rates. In 2004, he
recognized the need to develop the community’s own tailored, rural solution to this epidemic.
This required taking a balanced approach to OUD treatment and support services to prevent
overdose deaths, while also providing responsible pain management to those in need.
Project Lazarus began with two years of raising awareness across all community sectors (e.g.,
residents, schools, law enforcement, human services, hospitals, and medical providers) about the
local opioid problem. As part of this process, organizers identified potential solutions to the local
opioid problem and the role of each community sector in implementing those solutions.
Identified strategies included building treatment resources for providers; enhancing linkages
between medical providers, pain programs, and substance use treatment services; and working
with state and local entities to better fund mental health services. It also included a public
education campaign to combat stigma and work with a provider to establish MAT services in
Wilkes County that now serve 400 to 500 patients per day.
According to the program’s founder, communities wishing to replicate Project Lazarus should
start “where the energy is” around OUD, creating change from within the community and
building a coalition of local organizations, providers, and stakeholders. He also stressed that
16
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finding the right balance of prevention, intervention, and treatment for each community is critical
to success.
Project Lazarus is built around a set of core “prerequisite” components, which reflect a
community-based, bottom-up public health approach (Figure 1).52 This approach focuses on
building awareness of opioid use through broad-based educational efforts and the use of local
data to drive awareness; building coalitions to engage community providers, agencies, and
organizations; and assembling data to build awareness, tailor programs to local needs, track
progress, and sustain support and funding. Communities are also encouraged to select from
optional evidence-based prevention initiatives to address unique local needs. These include
community and provider education, hospital ED policies, diversion control, support for pain
patients, harm reduction, and addiction treatment.
Figure 1: Core and Optional Components of the Project Lazarus Model

Source: Injury Prevention Research Center. Lessons Learned from Implementing Project Lazarus in North Carolina.
Chapel Hill, NC: University of North Carolina at Chapel Hill, IPRC; August, 2016.
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Program stakeholders report that overdose deaths in Wilkes County declined by 69 percent from
2009 to 2011 and the gap between Wilkes County and the nation narrowed.42,52,53 Opioid
overdose deaths in Wilkes County have declined from 46.6 per 100,000 in 2009 to 14.4 deaths in
2011. The program has also impacted local prescribing patterns. In 2008, 82 percent of opioid
overdose deaths received their prescription from local prescribers. In 2011, this percentage was
zero. ED visits for overdose and OUDs declined by more than 15 percent between 2009 and
2010 in Wilkes County compared to a 6.9 percent increase statewide.
With funding from the Kate B. Reynolds Trust, the North Carolina Office of Rural Health,
Community Care of North Carolina, and the Mountain Area Health Education Center, Project
Lazarus has expanded to all 100 counties in North Carolina.52 Program staff have provided
technical assistance to facilitate adoption of the model in communities in more than 13 states,
tribal communities, and the U.S. military.52 Examples include Operation OpioidSafe, Project
Bald Eagle in Lycoming County, Pennsylvania (recognized as the 2015 Rural Health Program of
the Year by the Pennsylvania Office of Rural Health), and the Washtenaw Health Initiative,
Washtenaw County, Michigan.52,54,55
Supporting Primary Care Providers Treating Chronic Pain: Washington State’s
TelePain Program
Lacking specialty pain management training, many rural providers are not aware of, or do not
adhere to the latest evidence-based opioid prescribing guidelines, contributing significantly to the
opioid crisis. To address this problem, the University of Washington (UW) School of Medicine’s
Division of Pain Management developed a “TelePain” program to increase primary care
providers’ pain management and opioid prescribing skills.56 The program is based on the Project
ECHO ‡ model and available to clinicians in Washington, Wyoming, Alaska, Montana, and
Idaho. The program conducts weekly videoconferences using UW’s pain management specialists
and includes didactic presentations from the UW Pain Medicine curriculum, case presentations
from community clinicians, interactive consultations with pain specialists, and the use of
measurement-based clinical instruments to assess treatment effectiveness and outcomes.

‡

Project ECHO (Extension for Community Healthcare Outcomes) is a collaborative model of technology-based
medical education and care management developed at the University of New Mexico, School of Medicine
(http://echo.unm.edu/about-echo/). It connects front-line clinicians in rural and underserved areas with specialty
clinicians through in a continuous learning system through regularly scheduled case and subject-based conferences.
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Community providers present complex chronic pain cases and receive input from specialists with
expertise in pain medicine, internal medicine, anesthesiology, rehabilitation medicine,
psychiatry, addiction medicine, and nursing care coordination. The program offers a second
weekly teleconference on veterans’ health care for Veteran Affairs’ providers and others working
with veterans.
According to key informants, the TelePain Program increases community providers’ access to
educational and consultative support for pain management, improves patient outcomes, and
enhances patient and provider satisfaction. The program also helps to meet the need for pain
management specialist consultations required by the Washington State Department of Health’s
regulations for opioid prescribing.
The program is supported by grant funding and the service is typically not third party
reimbursable. Although community providers find value in the program, it may not be
sustainable unless an additional source of support is found when current funding expires.
Program leaders noted a path to sustainability might include support from accountable care and
managed care organizations that would find the TelePain program to be helpful in managing the
chronic pain management needs and related costs of their patient populations.
Hospital Emergency Department (ED) Strategies for Managing Opioid Access:
Washington State’s ED Prescribing Guidelines and the “Oxy Free” ED
In 2008, the Washington State Department of Health established an interagency workgroup to
develop guidelines for opioid prescribing in EDs. Members were recruited from state agencies,
emergency, pain, and addiction providers, health plans, law enforcement, public health, and the
University of Washington’s School of Medicine. The resulting guidelines included limitations on
the prescription of opioids in EDs and the concept of an “Oxy-free zone” (in which the ED
would limit prescribing of the class of drugs that include OxyContin and discontinue the practice
of replacing lost or stolen opioid prescriptions).57
The Washington Chapter of the College of Emergency Physicians sponsored the new guidelines,
which were endorsed by the state medical, hospital, and emergency nurses associations.
Washington’s Medicaid program adopted the guidelines as one of seven best practices to reduce
unnecessary ED use. The initiative has helped to reduce the rates of ED visits by “frequent
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users” seeking opioid prescriptions by individuals with low-acuity diagnoses.58 The Medicaid
program has estimated ED savings in their non-managed care population at $33.6 million.
Interviewees noted that hospitals were pleased with this strategy but some experienced initial
reductions in patient satisfaction scores related to pain management. Nevertheless, rural hospitals
in other states have expressed interest in this concept and some have already implemented the
Oxy-free policy.
Models to Expand Medication-based Treatment: Vermont’s Hub and Spoke
Network
Stakeholders across the four states reported problems in accessing methadone treatment services
in specialty OTPs or buprenorphine services in primary care and other settings. Buprenorphine
treatment is widely promoted as a model for rural communities as it has a lower abuse potential
than methadone and can be prescribed by primary care and other physicians who obtain the
appropriate SAMHSA waiver. Despite this support, many physicians receiving waivers do not
actually employ buprenorphine in their practices.59 Lack of mental health and psychosocial
supports and the lack of time needed to provide MAT within busy primary care practices are the
most commonly reported barriers to buprenorphine prescribing.60
To address these barriers, Vermont developed a comprehensive system that includes medicationbased treatment, behavioral support, and recovery services. Under Vermont’s Blueprint for
Health, the state, in collaboration with local health, addiction, and mental health providers,
implemented the statewide Care Alliance for Opioid Treatment initiative. Using a “hub and
spoke model” (Figure 2), this initiative has:


Designated five regional specialty treatment centers as the “hubs” responsible for
coordinating the care of individuals with complex OUDs and co-occurring substance use
and mental health disorders. Hubs provide comprehensive assessments and treatment
protocols; initiate methadone, buprenorphine, or antagonist treatment for clinically
complex clients; provide care during the initial stabilization period; coordinate referrals
to ongoing care; and provide specialty addictions consultation for care provided by
primary care and others prescribing buprenorphine.



Designated physicians prescribing buprenorphine and collaborating health and addictions
professionals to serve as “spokes”. Spoke providers dispense buprenorphine, monitor
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adherence to treatment, coordinate access to recovery supports, and provide counseling,
contingency management, and case management services. Spokes can be Blueprint
Advanced Practice Medical Homes, outpatient substance use treatment providers,
primary care providers, Federally Qualified Health Centers, and independent
psychiatrists.
•

Developed health home services providing care coordination, health promotion,
transitions of care, and community support to Medicaid beneficiaries with OUDs.



Adopted Vermont’s Community Health Team model to offer in-office supports to spoke
physicians through embedded clinical staff (a nurse and a Master’s prepared, licensed
clinician) providing the health home services discussed above.



Expanded access to methadone treatment by opening a new program in southwest
Vermont (Rutland) and supporting providers to serve all appropriate patients who are
currently on waiting lists.
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Figure 2: Vermont’s Hub and Spoke Model

Source: Cimaglio B. The Opioid Addiction Treatment System. Burlington, VT: Vermont Agency of Human Services,
Department of Health; January 15, 2013.

Specific services provided through the Care Alliance for Opioid Treatment include:
•

Comprehensive care management: Screening programs, initial assessments, care
planning, and care management across the continuum of physical health, behavioral
health, and social services.

•

Care coordination and referral to treatment and support services: Implementation and
monitoring of plans of care (with patient engagement), referral to services, and
coordination of service and supports across treatment and human services providers.

•

Care transitions: Systems to facilitate movement of patients across treatment settings,
levels of care, and physical health, mental health, substance use, and long term care
providers.
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•

Individual and Family Supports: Advocacy, family assessments, education about
available resources, and patient/family engagement in the care process.

•

Health Promotion: Promotion of patient activation and empowerment, shared decisionmaking, and self-management of health, mental health and substance use conditions.

With the implementation of this initiative, Vermont has increased the number of physicians
certified to prescribe buprenorphine and willing to treat opioid patients. Key informants report
that some primary care practices have doubled the number of patients they will carry for
treatment. According to key informants, preliminary Medicaid data show that the quality of care
has increased, even in rural areas.61 They attribute their success to additional staffing and support
provided by the community health teams and improved access to specialty substance use support
and treatment services.
Vermont’s Care Alliance for Opioid Treatment initiative was created through Medicaid State
Plan Amendments. Both the hubs and spokes receive a per-member, per-month reimbursement to
care for individuals with OUD, as well as the additional staffing support for the care
management services described above. Participating spoke sites are provided with support staff
(a nurse and clinician case manager) whose salaries are paid by the Medicaid program. The level
of enhanced staffing is modeled at one full time equivalent (FTE) nurse and one FTE licensed
clinician case manager for every 100 MAT patients with the exact level of staffing prorated
based on the number of patients carried by the provider. In a 2015 report presented to the
Vermont State Legislature, the Commissioner of Health reported a variety of system
improvements resulting from the operation of the Care Alliance for Opioid Treatment including:
•

The opening of a new hub facility in Rutland;

•

The addition of supportive health home services resulting in more comprehensive care;

•

A 40 percent increase in the number of people receiving care with approximately 70
percent of Medicaid recipients with an opioid dependence diagnosis in 2013 receiving
MAT services; and

•

Improved care, with the majority of those receiving treatment remaining in treatment
longer, and improved functioning at discharge for those who remained in treatment for
more than 90 days.43
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Supporting Community Buprenorphine Prescribers: Washington State’s Project
ROAM
In a project similar to the TelePain Program described earlier, Project ROAM (Rural Opiate
Addiction Management) represents an alternative model to support buprenorphine services in
rural communities. Developed through the collaboration of the University of Washington School
of Medicine’s Department of Family Medicine and Washington State University – Spokane,
Project ROAM was implemented in 2010 to support rural physicians prescribing buprenorphine.
Funded by tobacco settlement money, it offered continuing medical education courses, using a
Project Echo style teleconferencing system, to enable physicians to qualify for the SAMHSA
buprenorphine waiver.62 To further support new buprenorphine prescribers, the program paired
participants with course instructors in a mentoring relationship; provided practice management
consultation on billing issues, clinical protocols, reporting forms, and staff training; and offered
clinical grand rounds through which participants could present difficult cases and obtain
feedback from the group. Although 10 to 15 rural physicians participated regularly, primary care
physicians reported that it was difficult to commit the time to participate in the telehealth based
conferences on a regular basis.
With the loss of tobacco funding, however, the program has been discontinued. According to one
of the program organizers, Project ROAM was successful but difficult to sustain without grant
funding as the service is not third party reimbursable.
Strategies to Support Recovery and Reduce Relapse in Rural Communities:
Vermont’s Recovery Support Network
Much of the discussion on the opioid crisis focuses on expanding treatment services,
implementing harm reduction strategies, expanding the use of prescribing guidelines, and
reducing the supply of opioids. Interviewees emphasized, however, the importance of recovery
services to support individuals with opioid issues after treatment. They noted that many people
with OUDs, particularly in rural communities, have a difficult time re-engaging in work and the
community without falling back into the same situations and peer groups that supported their
substance use habits. As such, it is important to provide access to recovery support services. The
Vermont Recovery Network offers a model that can be adopted in rural communities.
The Network supports 11 Turning Point Recovery Centers (TPRCs) with funding from the state
and federal (SAMHSA) grant funds. The TPRCs serve communities across the state; at least one
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TPRC was described as serving a very small rural community. According to the Director, few
Vermont communities have the ability to support a recovery center on their own. The exceptions
are White River Junction (large rural) and Burlington (urban).
The Network provides facilitation, oversight, and basic infrastructure support. TPRCs are “local,
consumer driven, non-residential programs which provide peer supports, sober recreation
activities, volunteer opportunities, community education, and recovery support services”.63 The
TPRCs offer peer supervision for staff and volunteers. Each TPRC must agree to the Network’s
expectations regarding management, oversight, and adherence to principles in the service plan;
development of operating rules, by-laws, personnel policies, procedures; participation in
Executive Council and quarterly Network meetings; and collection of data to demonstrate the
effectiveness of recovery support services.
Key informants noted that the TPRCs provide non-clinical services to assist people with
substance use disorders make the necessary connections to find employment, housing, and other
needed social services. The mission of the Network is to “support people in their efforts to
maintain recovery, in preventing relapse, and, should relapse occur, assisting in their return to
recovery.”63 In addition to individual recovery services and coaching, various TPRCs offer
services and groups that target specific populations (e.g., youth and adolescents, veterans,
parents of youth with substance use disorders, individuals undergoing MAT or drug court, and
individuals with co-occurring disorders) or certain aspects of recovery.64 The TPRCs also offer
social and recreational programming, parenting skills training, and writing groups.
The TPRCs use a peer-based recovery coaching model to assess where individuals are in their
recovery, their readiness to change, and what can be done to assist them in that recovery. Staff
and volunteers are recruited due to their own histories of substance use. Peer support specialists
and counselors receive training and are required to obtain continuing education units. Program
officials report significant changes in participants’ use of emergency services and engagement
with the criminal justice system.
Harm Reduction Strategies: Indiana’s Needle Exchange Programs
The rapid spread of HIV and HCV in rural Scott County, Indiana due to injection drug use
highlights the importance of needle exchanges as a harm reduction strategy for injection drug
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users. Initially prohibited by Indiana state law, the governor declared a public health emergency
in Scott County in March 2015, and later other Indiana counties, thereby allowing him to
suspend the law. Public health stakeholders in Indiana reinforced the important role of expanding
access to clean needles through needle exchanges in reducing the spread of HIV and HCV
among injection drug users in Scott County.38,65 Since 2015, needle exchange programs have
also been implemented in Madison and Monroe Counties and another 20 counties are exploring
the development of needle exchanges based on local injection drug use.65 Although public health
stakeholders have applauded the development of needle exchanges and noted their success in
reducing the spread of HIV and HCV, some have described a number of implementation issues
that have hindered the effectiveness of the Scott County needle exchange program.38 These
issues have included inadequate funding to support the purchase of sterile needles by the
exchange, rules requiring injection-drug users to register with their initials and date of birth to
obtain needles, limited operating hours, and the ongoing prosecution of unregistered injectiondrug users for carrying syringes.
IMPLICATIONS FOR POLICY AND PRACTICE
In summarizing and distilling the key lessons from these four states for rural policymakers and
community stakeholders, we found that many of the strategies and interventions identified do not
have a uniquely rural focus. For example, efforts to develop and disseminate treatment
guidelines are equally applicable to urban and rural settings. The same is true for harm reduction
strategies involving needle exchanges and naloxone use or programs that offer treatment and
support to non-violent opioid users as an alternative to incarceration. We therefore focused our
attention on strategies and interventions that demonstrate how resource-constrained rural
communities can begin to address gaps in OUD prevention, treatment, and/or peer support and
recovery.
The experiences of these four states demonstrate the critical importance of community
engagement and education as the foundation for developing a comprehensive set of education,
prevention, treatment, care coordination, peer support, and recovery services. Given the
complexity of opioid use in rural communities, strategies and tools such as those offered by
Project Lazarus are critical to educating and organizing community members and resources to
address the opioid crisis. Federal and state governments can provide funding, support, and
training, but the real work is on the ground, in communities. Those we spoke with noted the
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strength of rural communities and coalitions in addressing the needs of their communities during
this opioid crisis. As money, providers, and services in rural communities are in short supply,
broad-based coalitions are important as the problems and solutions cannot be owned by any one
entity. Participants may include representatives from health care, public health, social services,
law enforcement, local government, schools, faith-based organizations, business, and the
community. These efforts take time and resources but are an essential part of the process.
While Project Lazarus provides one model of community engagement, others can be equally
valuable. The keys are to supplement national and state data with data and input from local
stakeholders and community members, engage broad-based coalitions involving all sectors of the
community, and develop a transparent planning process to identify and address priority issues.
Helping community stakeholders to view opioid use as a public health issue and understand that
it is a chronic, relapsing disease that can be addressed successfully with evidence-based
strategies must be a major focus of efforts to address the opioid crisis. OUDs are not limited
solely to those that misuse heroin and prescription medications. Individuals prescribed opioids
for pain are equally at risk for opioid harms as those that obtain them illegally. This public health
approach to opioid use recognizes the complex interrelationship between prescription opioids
and heroin. Prescription opioids can be a gateway to heroin use, particularly as efforts to reduce
access to prescription opioids take effect and as the cost of heroin declines relative to
prescription opioids.
A greater focus on prevention and harm reduction is important to minimizing OUDs and
reducing opioid harms by directly educating the community (primary prevention), individuals at
greater risk for OUDs (secondary prevention), and individuals already engaged in dangerous
opioid use (tertiary prevention). In addition, states and communities can pursue a variety of
strategies to reduce the supply of opioids, including the use of prescribing guidelines, expanded
use of prescription drug monitoring programs by providers to monitor prescribing practices and
“doctor shopping,” law enforcement efforts to reduce drug trafficking, and take back/disposal
efforts to reduce access to prescription medications that are no longer needed.
The concept of harm reduction is closely aligned with a focus on prevention. In acknowledging
that OUDs are a chronic illness (rather than a moral failing or enforcement/legal issue), states are
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implementing interventions that reduce the risk of harm to opioid users through needle
exchanges to reduce transmission of HIV and HCV, increased access to naloxone to reduce
overdose deaths, and expanded prevention, treatment, and recovery programs to reduce the
health consequences of OUDs.
The experiences of these states also make clear the importance of a comprehensive system of
care providing prevention, treatment, and recovery services. A comprehensive system of
substance use care is hard to develop in rural communities and typically requires regional
collaboration among providers to provide easily accessible medication-based treatment and
traditional substance use services, mental health services, and care coordination. Any one of
these component services on its own is insufficient to meet an opioid user’s full needs. MAT
services, for example, address a user’s craving for opioids but do not address other co-occurring
mental and physical health issues underlying opioid use. Traditional substance use and mental
health services are less effective without the craving control provided by MAT. Care
coordination services are essential to assisting individuals with OUDs in obtaining the full range
of behavioral health, physical health, social supports, and recovery services necessary to achieve
and maintain an opioid free life.
Federal and state governments and foundations can make important contributions to addressing
the opioid crisis in rural communities by funding evidence-based strategies and programs,
providing or expanding access to evidence-based interventions, supporting research into best
practices and dissemination activities, and strengthening the use of telehealth technology to
improve access to direct care services and consultative services to support rural clinicians. As
demonstrated by Washington State’s successful effort to develop ED prescribing guidelines,
inter-agency and inter-disciplinary collaborations at the federal and state levels are critical to the
development and implementation of programming and interventions to address the opioid crisis.
The strategies profiled in this report provide examples of pathways that other states and rural
communities can follow. Adopting these strategies will not immediately resolve the opioid crisis.
Inappropriate opioid use is a complex problem requiring comprehensive and sustained attention.
Currently, too little attention and funding has been given to the challenges rural communities
face in developing comprehensive interventions to address this crisis. To support such efforts,
expanded, long term funding and support will be needed. This includes expansion of third party
28
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reimbursement for OUD treatment services, expanded Medicaid coverage, comprehensive
education efforts targeting providers as well as community members, wide dissemination of
evidence-based best practices targeting the needs of rural communities, and focused research on
which strategies work in rural communities and provider organizations.

For more information about this study, contact John Gale at john.gale@maine.edu.
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